¢º È¿´ÉÆò°¡ ÆÀÀå
[¾÷¹«³»¿ë]- ¹æ»ç¼± ±â¼ú ±â¹Ý, in-vitro, in-vivo È¿´ÉÆò°¡- Radiation induced disease (Acute radiation syndrome, chemoradiation induced mucositis) Áúȯ µ¿¹° ¸ðµ¨ Á¦ÀÛ ¹× in-vitro È¿´ÉÆò°¡- Cell culture, cloning, trasfection, qRT-PCR, Western blot, IP, FACS, ELISA, IHC, Confocal MS ¸¦ ÅëÇÑ ¾à¹°±âÀü ¹× È¿´ÉÀÔÁõ- Team management - ¿¬±¸¼³°è, ±â¼úÁöµµ ¹× ÆÀ¿øÀÇ µ¿±âºÎ¿©
[ÀÚ°Ý¿ä°Ç]- Çз : ¹Ú»ç- °æ·Â : ¹Ú»ç ÈÄ 1³âÀÌ»ó- ±¹³»¿Ü ¹Ú»ç ÈÄ ½Å¾à°³¹ß°ü·Ã ±Û·Î¹ú º¥Ã³ ±Ù¹« °æ·Â- ±Û·Î¹ú ½Å¾à¿¬±¸°³¹ßÀ» À§ÇÑ ¶Ñ·ÇÇÑ ¸ñÇ¥¸¦ °¡Áö½Å ºÐ- Lipid ¼ÒÀç È¿´É ¹× ±âÀü¿¬±¸ °æÇèÀÚ (In-vitro, in-vivo efficacy, MOA) - Acute radiation syndrome, Chemoradiation induced mucositis, chemoradiotherapy À¯°æÇèÀÚ ¿ì´ë- ¿µ¾î ´ÉÅëÀÚ ¿ì´ë(ÇØ¿ÜÇÐȸ ¹ßÇ¥ ¹× ³í¹® ÀÛ¼º ¼öÁØ)
[±Ù¹«Áö] ¼¿ï
¡Ú¡Ú ±Ã±ÝÇϽŠ»çÇ×Àº ÀüÈ ¹®ÀÇ ¹Ù¶ø´Ï´Ù ¡Ú¡Ú
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£ J150002023003